Mylan Institutional Inc., A Viatris Company
VIATRIS™ is a new kind of healthcare company, committed to providing access to medicines, advancing sustainable operations, developing innovative solutions and improving patient outcomes. Formed in 2020 through the combination of Mylan and Upjohn, Viatris brings together best-in-class scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities.
Mylan is one of the world’s leading global pharmaceutical companies. Our portfolio of more than 7,500 marketed products includes generic, brand name and over-the-counter medicines in a variety of dosage forms and therapeutic categories. The company has innovative R&D capabilities and is one of the world’s largest active pharmaceutical ingredient manufacturers.